The University of Minnesota Molecular and Cellular Therapeutics Facility (MCT) has been selected as one of the 5 Cell Processing Facilities offering translational services and cell product manufacturing for pre-clinical studies to investigators at no charge under the National Heart, Lung, and Blood Institute-funded Production Assistance for Cellular Therapies (PACT) program. The PACT program is in its second renewal and has been providing services to cell therapy investigators since 2003. For more information please visit www.pactgroup.net.
Scope of Projects
PACT's objective is to promote the advancement of cellular therapy research in the areas of regeneration of damaged/diseased tissues, organs, and biologic systems, and targeted treatments for serious diseases without effective therapies in support of the NHLBI's program areas of interest: cardiovascular, pulmonary, blood, hematopoietic, and stem cell disorders. For qualifying areas of interest, please see the PACT Application: Scope Criteria located at www.pactgroup.net.